Showing 61 - 80 of 133 results
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
About 70 representatives from business and industry groups, local business chambers, councils and the education sector from southern Sydney heard about ANSTO’s Innovation Precinct.
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.
Neutron scattering instruments used by Japanese researchers.
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.
ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
Professor Vanessa Peterson, Senior Principal Research and Neutron Scattering Instrument Scientist and Leader of the Energy Materials Research project, has been awarded the Bob Cheary Award or Excellence in Diffraction Analysis by the Australian X-ray Analytical Association. She is the first female to be chosen for the award.